Back to Newsroom
Back to Newsroom

Biolab Strengthens Its Presence With the Purchase of Exzell Pharma

Tuesday, 09 August 2022 12:10 PM

MARKHAM, ON / ACCESSWIRE / August 9, 2022 / Biolab Pharma announced today the acquisition of the Canadian healthcare business, Exzell Pharma, based in Markham, Ontario. The deal represents another significant step to strengthen its international presence by acquiring a sales and marketing infrastructure as well as important established brands such as Swiss Naturals, Salinex, Esoph, and Myoflex.

Biolab Pharma is a subsidiary of Biolab Farmacêutica with headquarters in Brazil. The company arrived in Canada in 2017, with the establishment of a research and development facility. In this first phase, the priorities were to get a better grasp of the legislation and the product registration process, plus certifying the company's factories in Brazil for export.

"We are now ready for the next breakthrough, boosting our local structure with our own sales and marketing team, as well as incorporating leading products from Exzell Pharma", CEO Cleiton Castro Marques explained.

Exzell is the right partner to advance in the international market for many reasons, Marques stated, adding: "First, to create synergy in the portfolios. Also, Exzell has grown at an impressive rate. In addition, it sells products manufactured by third parties, which fits perfectly with our strategy." Biolab intends to rely on Exzell's experienced and committed team in order to achieve continuous growth in the Canadian pharmaceutical market.

Exzell maintains a portfolio focused primarily on gastroenterology, dermatology, vitamins, and supplements. The acquisition of Exzell and the incorporation of its product line will also help Biolab bring synergies to its own R&D efforts as well to its global licensing and partnering activities.

Marques points out, "Expanding our business globally has always been a goal worth taking at the right time. This is why we have structured ourselves to carry out the process gradually - without skipping over any steps. The first phase involved scouting out the markets - not just the Canadian market, but those in other highly regulated countries as well. We are now taking further steps towards making Canada our platform to reach other highly regulated markets."

This is another crucial step for Biolab, which can now operate commercially in a major global market and takes on the challenge towards its internationalization strategy.

About Exzell:

Exzell Pharma is a niche pharmaceutical company founded by biotech entrepreneur Dr. Par Nijhawan. Exzell sells both pharmaceutical and natural health products into the Canadian marketplace. Our staff are dedicated to advancing healthcare for Canadians. We actively seek out new and innovative products for many therapeutic areas. Exzell Pharma is privately owned and based in Markham, Ontario.

With a mission to bring innovative products from around the world to the Canadian market, Exzell Pharma aims to provide new, more effective treatment options in areas of unmet patient need. We are driven to become a leading source of safe, effective and affordable health products in Canada. We are committed to improving the overall quality of life of the patients who use our products.

About Biolab:

Biolab Pharma is a leading pharmaceutical company with headquarters in Brazil. Biolab is committed to the development of science and the pharmaceutical industry with a portfolio spanning over 100 products, we are a vibrant company, committed to the future and investing about 10% of our revenue in Research, Development and Innovation. Here at Biolab, we believe that health and quality of life are crucial conditions for people to live their lives to the fullest. We research, develop, manufacture and commercialize medication and natural health products with the purpose of promoting healthier lives.


Jose Rodriguez
[email protected]

SOURCE: Biolab Pharma

Mergers and Acquisitions
Back to newsroom
Back to Newsroom
Share by: